Health Care/Hospital

Li Jian Quan, Chairman of WINNER MEDICAL Co., Ltd., Was Invited to "DIALOGUE PROGRAM" in CCTV-2 (China Central Television)

SHENZHEN, China, Jan. 7, 2022 /PRNewswire/ -- On the evening of January 1, Li Jian quan, chairman of Winner Medical, was a guest on "DIALOGUE PROGRAM" in CCTV-2 (China Central Television) as a representative of entrepreneurs. In the interview, he said that only by insisting on innovation can we b...

2022-01-07 17:47 1850

InnoCare to Attend Upcoming Investor Conferences to Share Latest Company Development

BEIJING, Jan. 7, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biotech company, announced today that the company executives will attend the upcoming investor conferences organized by Morgan Stanley and UBS to share company's latest development. Details are as follows: Morgan Stan...

2022-01-07 08:30 2105

Pudu Robotics' New Afra C1 Cleaning Robot Makes its Global Debut at CES 2022

LAS VEGAS, Jan. 6, 2022 /PRNewswire/ -- Pudu Robotics, the global leader in commercial service robots, has enhanced its rich product portfolio with its new Afra C1 cleaning robot, which made its global debut on day one of CES 2022. The first international appearance of Afra C1 marks Pudu Robotics'...

2022-01-07 00:00 1884

LISCure Biosciences announces research collaboration with Mayo Clinic for rare liver diseases

SEOUL, South Korea, Jan. 6, 2022 /PRNewswire/ -- LISCure Biosciences Inc., a leading biotech focused on microbial-based therapeutics, announced that it has executed a research collaboration agreement with Mayo Clinic for new drug development for rare liver diseases. LISCure has been conducting j...

2022-01-06 22:00 1625

Happiness Development Announces Financial Results for the Six Months Ended September 30, 2021

NANPING, China, Jan. 6, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ: HAPP) aChina-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce sales and e-commerce marketing solutions, and the s...

2022-01-06 21:00 3354

I-Mab Announces Senior Management Team Share Purchase Plan

SHANGHAI and GAITHERSBURG, MD., Jan. 6, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that the senior management team of the Company, includin...

2022-01-06 21:00 3601

Alterity Therapeutics Granted New US Patent for Compounds for Neurodegenerative Diseases Including Parkinson's and Alzheimer's

MELBOURNE, Australia and SAN FRANCISCO, Jan. 6, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced the United States Patent ...

2022-01-06 20:30 3175

AKESO'S CADONILIMAB (PD-1/CTLA-4 BI-SPECIFIC ANTIBODY) COMBINED WITH IVONESCIMAB (PD-1/VEGF BI-SPECIFIC ANTIBODY) COMBINED WITH OR WITHOUT CHEMOTHERAPY OBTAINED APPROVAL TO INITIATE A PHASE Ib/II CLINICAL TRIAL FOR THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER

HONG KONG, Jan. 6, 2022 /PRNewswire/ -- Today, Akeso, Inc. (09926.HK) announces that Cadonilimab (PD-1/CTLA-4 bi-specific antibody), the  first-inclass novel immuno-oncology drug independently developed by the Company, combined with Ivonescimab (PD-1/VEGF bi-specific antibody), the novel immuno-o...

2022-01-06 19:00 2264

Nuance Pharma acquires Sino Health to further strengthen its commercial capabilities and expand pipelines

SHANGHAI, Jan. 6, 2022 /PRNewswire/ -- Nuance Pharma ("Nuance"or the "Company"), a specialty care focused biopharma with late late-stage clinical programs and existing commercial operations, today announced an agreement with Sino Health Pharmaceutical Limited ("Sino Health") , an affiliated compa...

2022-01-06 14:45 2763

Ascentage Pharma to Present at the J.P. Morgan 40th Annual Healthcare Conference

SUZHOU, China and ROCKVILLE, Md., Jan. 5, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced its participation in and presentation at the 40th A...

2022-01-06 08:30 7167

Adlai Nortye Announces First Patient Dosed in Phase I Clinical Trial of the orally available, small-molecule PD-L1 inhibitor AN4005 for Advanced Tumors

NORTH BRUNSWICK, N.J. and HANGZHOU, China, Jan. 5, 2022 /PRNewswire/ -- Adlai Nortye Ltd. ("Adlai Nortye"), a clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies, announced that the first patient was dosed in the Phase I clinical trial in the U.S. to...

2022-01-06 01:00 2002

Metavention Completes U.S. Enrollment in Groundbreaking Feasibility Study to Treat Type 2 Diabetes

MINNEAPOLIS, Jan. 5, 2022 /PRNewswire/ -- Metavention, Inc. announces the completion of enrollment in the DeLIVER U.S. Study (NCT04285554), to evaluate the safety of sympathetic denervation of the liver using its new Integrated Radio Frequency (iRF) Denervation System. The purpose of the DeLIVER...

2022-01-05 22:00 1606

ITRI Introduces Health Tech Innovations at CES 2022

HSINCHU, Jan. 5, 2022 /PRNewswire/ -- The Industrial Technology Research Institute (ITRI) , Taiwan's largest and one of the world's leading high-tech applied research institutions, today announced it will introduce health technologies at its CES 2022booth 9513, North Hal...

2022-01-05 21:00 1766

Alterity Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference

MELBOURNE, Australia, Jan. 5, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced thatDavid Stamler, M.D., Chief Executive Of...

2022-01-05 20:45 3185

Coway Unveils New Smart Home Solutions at CES 2022

* Coway introduces its Smart Care Air Mattress and Smart Sleep Solution, combining its latest Sleep and Air Care innovation, for the first time with an interactive experience exclusively at the booth * Exhibit also features new "Noble Collection," highlighting Coway's impressive product desig...

2022-01-05 13:02 1971

Accro Bioscience inks over $50M series B round

SUZHOU, China, Jan. 4, 2022 /PRNewswire/ -- Accro Bioscience (Suzhou) Co., LTD. ("Accro Bioscience"), aChina-based leading biotechnology company, announced that the company has recently raised over$50 million in an oversubscribed Series B round. The financing was led by Hongtai Aplus with partici...

2022-01-05 11:08 1542

PRISM BioLab, enters multi-project drug discovery collaboration with Roche and Genentech

TOKYO, Jan. 4, 2022 /PRNewswire/ -- PRISM BioLab, a Japan based biotechnology company with a proprietary peptide mimetic small molecule drug discovery platform, today announced it has entered into a multi-target research collaboration and licensing agreement with Roche and Genentech, a member of ...

2022-01-05 09:00 1778

BIORCHESTRA, SK Biopharmaceuticals collaborate to develop miRNA-targeted therapeutics

SEOUL, South Korea, Jan. 4, 2022 /PRNewswire/ -- BIORCHESTRA and SK Biopharmaceuticals announcedtoday that they have forged a partnership to research and develop new therapeutic compounds targeting microRNAs [1] (miRNA) for a potential treatment of epilepsy.

2022-01-05 08:07 1901

Hutech Massage Chair First Unveiling of "Sonic Wave Car Seat" at CES 2022, Strengthening global presence

* Hutech participates in CES 2022, the IT and home appliance exhibition at the world's largest scale this January * Plan to introduce a sonic wave car seat, sonic wave foot massager, sonic wave stretching mat * Plan to establish an overseas presence by launching a lineup of products incorpo...

2022-01-04 21:00 1598

Zepp Health To Host Wearables Data in Healthcare State-of-the-Union Event with Industry Thought Leaders on January 5, 2022

CUPERTINO, Calif., Jan. 4, 2022 /PRNewswire/ -- Zepp Health Corp. (NYSE: ZEPP)  today announced that it will host an event to share thoughts among industry leaders on the current state and path forward in the use of data in healthcare from smart wearable devices.  Speakers will include: * Zepp ...

2022-01-04 20:00 1834
1 ... 179180181182183184185 ... 278